GGrantIndex
Sort

21,453 grants matching tuberculosis

GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection

$615,656
Katherine B Hisert · National Jewish Health · R01 · FY2023 · HL

Chemotherapeutics Against Multi-Drug Resistant Tuberculosis

$615,510
Peter J Tonge · State University New York Stony Brook · U01 · FY2008 · AI

Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes

$615,075
Krishna P Reddy · Massachusetts General Hospital · R01 · FY2023 · DA

HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection

$615,075
Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI

Clinical Core

$615,050
Neel Rajnikant Gandhi · Emory University · U19 · FY2020 · AI

PK/PD Evaluation Resistance Development in Caseating Granuloma

$615,040
William Ramses Bishai · Johns Hopkins University · R01 · FY2008 · AI

Novel Mechanisms of Pulmonary Fibrosis

$614,922
Francis X McCormack · University Of Cincinnati · R01 · FY2024 · HL

TUBERCULOSIS ELIMINATIONS AND LABORATORY GRANT APPLICATION

$614,810
Lynn E Sosa · Connecticut State Dept Of Public Health · U52 · FY2011 · PS

Poor Treatment Response and Outcomes in Bedaquiline-Based Treatment Regimens for Drug-Resistant Tuberculosis in South Africa

$614,798
Yuri F. Van Der Heijden · Vanderbilt University Medical Center · R01 · FY2022 · AI

GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS

$614,730
Immune Disease Institute, Inc. · R01 · FY2004 · HL

Antibacterial Host Defense

$614,727
Robert Munford · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Defining how the spectrum of latency affects reactivation of TB

$614,716
Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · HL

Role of CD8 T cells in immunity to tuberculosis

$614,572
University Of Illinois At Chicago · R01 · FY2004 · RR

Rapid Immune Restoration and Lung Injury in HIV/TB

$614,410
Gregory P. Bisson · University Of Pennsylvania · R01 · FY2016 · AI

Bacterial Determinants of TB Progression

$614,368
David R Sherman · Seattle Biomedical Research Institute · U19 · FY2016 · AI

Pyroptosis maintains the integrity of a granuloma

$614,317
Edward A Miao · Duke University · R01 · FY2025 · AI

Tulane National Primate Research Center

$614,296
Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2008 · RR

Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial

$614,073
Adithya Cattamanchi · University Of California, San Francisco · R01 · FY2019 · HL

Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential

$614,066
Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2009 · AI

Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome

$614,035
Christoph Grundner · Seattle Children'S Hospital · R01 · FY2024 · AI

Role of mycobacterial dynamin-like proteins in the biogenesis of membrane vesicles, and host-pathogen interactions

$614,027
Gloria Marcela Rodriguez · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI

Role of mycobacterial dynamin-like proteins in the biogenesis of membrane vesicles, and host-pathogen interactions

$614,027
Gloria Marcela Rodriguez · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring

$614,002
Anna M Mandalakas · Baylor College Of Medicine · R01 · FY2020 · AI

Effectiveness of the TB Contact Priority Model

$613,791
University Of Alabama At Birmingham · R01 · FY2005 · HL

Biomarkers and Signaling in Tuberculosis

$613,683
William Ramses Bishai · Johns Hopkins University · R01 · FY2012 · AI